title: Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
authors.affiliation: Centre for Hemostasis, Thrombosis and Atherosclerosis Research, Academic Medical Centre, Amsterdam, The Netherlands.
authors.forename: M T
authors.initials: MT
authors.lastname: Nurmohamed
authors.forename: J
authors.initials: J
authors.lastname: Fareed
authors.forename: D
authors.initials: D
authors.lastname: Hoppensteadt
authors.forename: J M
authors.initials: JM
authors.lastname: Walenga
authors.forename: J W
authors.initials: JW
authors.lastname: ten Cate
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004353:Drug Evaluation, Preclinical; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D006025:Glycosaminoglycans / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006497:Heparan Sulfate; D006801:Humans; D015994:Incidence; D008322:Mammals; D008970:Molecular Weight; D010974:Platelet Aggregation / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D011817:Rabbits; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000139:chemically induced; D013924:Thrombophlebitis / Q000453:epidemiology / Q000517:prevention & control; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid